Skip to content
Roboearth – Lifestyle
Author:
Rafael Holdings, Inc.
Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results
June 11, 2026
Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C
June 10, 2026
Rafael Holdings Announces Patent Licensing Agreement with MIT for “Small Molecules to Improve Myelination in ApoE4 positive Alzheimer’s Disease”
April 22, 2026
Rafael Holdings Reports Second Quarter Fiscal 2026 Financial Results
March 16, 2026